Analysis: Physicians act as gatekeepers for new diagnostic tools

Frost & Sullivan reports that the number of diagnostic tests for cancer is growing at a rapid pace, but that physicians act as gatekeepers in the system, essentially preventing patients access to diagnostic tools that could save their lives. "Closing this gap is critical and companies are already striving to form partnerships involving diverse groups such as researchers, treatment professionals, policymakers at all levels, consumers as well as the public and private health sectors," says research analyst Raghavendra Chitta.

- read this press release for more

Suggested Articles

The public financing will enable Monopar to start a phase 3 trial of a prophylactic treatment for a side effect of chemoradiotherapy. 

The dispute centers on whether Asa Abeliovich used Alector’s confidential information in connection with his work for Prevail Therapeutics.

GSK poaches Merck KGaA's Martinez-Davis to helm pharma stateside; Bulto named Novartis U.S. pharma head; Allergan's Saunders set for huge parachute.